Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK2 | P49760 | 12/20 | 0.61 |
| ▸ | DYRK1A | Q13627 | 12/20 | 0.61 |
| ▸ | CLK3 | P49761 | 11/20 | 0.61 |
| ▸ | WNT1 | P04628 | 9/20 | 0.57 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19645547 | 0.93 | CLK2 (0.62) | CLK2DYRK1ACLK3WNT1 | |
| SCHEMBL17587069 | 0.90 | CLK2 (0.75) | CLK2DYRK1ACLK3WNT1 | |
| SCHEMBL20244185 | 0.89 | CLK2 (0.76) | CLK2DYRK1ACLK3WNT1 | |
| SCHEMBL17587059 | 0.86 | CLK2 (0.80) | CLK2DYRK1ACLK3WNT1TGFBR1 | |
| SCHEMBL17583412 | 0.86 | WNT1 (0.77) | CLK2DYRK1ACLK3WNT1TGFBR1 | |
| SCHEMBL19645499 | 0.85 | CLK2 (0.69) | CLK2DYRK1ACLK3WNT1TGFBR1 | |
| SCHEMBL19363564 | 0.85 | CLK2 (0.53) | CLK2DYRK1ACLK3WNT1TGFBR1 | |
| SCHEMBL19645614 | 0.85 | CLK2 (0.66) | CLK2DYRK1ACLK3WNT1TGFBR1 | |
| SCHEMBL17587066 | 0.85 | WNT1 (0.76) | CLK2DYRK1ACLK3WNT1TGFBR1 | |
| SCHEMBL17587057 | 0.84 | CLK2 (0.71) | CLK2DYRK1ACLK3WNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9828372-B2 | 2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof | SAMUMED, LLC (US) | 2017-11-28 | — | — | US | disclosed |